Carcinoma, Non-Small-Cell Lung Clinical Trials in West Valley City, Utah
4 studies are recruiting for carcinoma, non-small-cell lung in West Valley City, Utah right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
The purpose of this study is to find out whether the study drug, Sofetabart Mipitecan (LY4170156), is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in three parts - phase Ia (dose-escalation, dose-optimization), phase Ib (dose-expansion), and phase…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- START Mountain Region, West Valley City, Utah
- Locations
- 24 in total
- Run by
- Eli Lilly and Company
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to your body besides treating your disease. Participants will have solid tum…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- START Mountain Region, West Valley City, Utah
- Locations
- 62 in total
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
-
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- South Texas Accelerated Research Therapeutics Mountain Region, West Valley City, Utah
- Locations
- 48 in total
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
-
A Study of LY4175408 in Participants With Advanced Cancer
The purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, this study will evaluate how much LY4175408 gets into the bloodstream, how it is broken down, and how long it takes the body to get rid of it. Participation could…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- START Mountain Region, West Valley City, Utah
- Locations
- 27 in total
- Run by
- Eli Lilly and Company
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.